絞り込み

16546

広告

Afatinib treatment for her-2 amplified metastatic colorectal cancer based on patient-derived xenograft models and next generation sequencing.

著者 Yang M , Fang X , Li J , Xu D , Xiao Q , Yu S , Hu H , Weng S , Ding K , Yuan Y
Cancer Biol Ther.2018 Oct 11 ; ():1-6.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (20view , 0users)

Full Text Sources

Miscellaneous

Substantial progress has been made in metastatic colorectal cancer (mCRC) treatment, but there is still a fraction of patients cannot find any effective therapeutic strategy after guideline-recommended standard chemotherapy and molecular targeted therapy.
PMID: 30307354 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード